Dioseve logo

Dioseve

creating human eggs from iPS cells

5 employees · est. 2021 · Japan

VS
Hercules Pharmaceuticals logo

Hercules Pharmaceuticals

Driving Innovation in Non-Toxic Oral Therapies for Triple Negative Breast Cancer and Solid Tumors

est. 2013

Hercules Pharmaceuticals is the older company (2021 vs 2013).

Side-by-Side Comparison

Dioseve Hercules Pharmaceuticals
Founded
2021 2013 older
Headquarters
Japan Not tracked yet
Employees
5 Not tracked yet
Industry
Biotechnology, Health Care Biopharma, Biotechnology
Funding Stage
Unknown Seed
Total Funding
$407.00M $300.00K
Funding Rounds
2 1
Services
developing solutions for infertility using stem cell technology, inducing egg and sperm cells from iPS cells, innovative reproductive health solutions Not tracked yet
Target Customers
individuals facing infertility, couples desiring children, healthcare providers Not tracked yet
Taxonomy
IPS Cells, ES Cells, Fertility Technology, Oocyte Creation, Infertility Treatment, Reproductive Innovation, Stem Cell Research, Fertility Solutions, Reproductive Health Biopharmaceutical, Oral Therapy, Non-toxic, Triple Negative Breast Cancer, Solid Tumors, Aryl Hydrocarbon Receptor, Anti-cancer Drugs, Clinical Trials, Cancer Treatment, Immunotherapy, Metastasis, Chemotherapy, Cancer Research, Drug Development, Oncology
Website
dioseve.com hercules-pharma.nl
Dioseve logo

About Dioseve

Dioseve is a burgeoning player in the Biotechnology and Health Care industries, poised to transform infertility treatments. Founded in 2021, the company is headquartered in Japan and is devoted to the pioneering mission of "creating human eggs from iPS cells." Through its cutting-edge technology tha...

Hercules Pharmaceuticals logo

About Hercules Pharmaceuticals

Hercules Pharmaceuticals is a biopharmaceutical company founded in 2013 with a mission to develop innovative, oral, non-toxic drug therapies for patients with Triple Negative Breast Cancer and other solid tumors. The company's focus on inhibiting the Aryl hydrocarbon Receptor in solid tumors has sho...

We will tell you when either one moves

BounceWatch watches Dioseve and Hercules Pharmaceuticals for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Dioseve and Hercules Pharmaceutica... — by email.

Frequently Asked Questions

Dioseve — creating human eggs from iPS cells. Hercules Pharmaceuticals — Driving Innovation in Non-Toxic Oral Therapies for Triple Negative Breast Cancer and Solid Tumors. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Dioseve has raised $407.00M while Hercules Pharmaceuticals has raised $300.00K.
Dioseve and Hercules Pharmaceuticals operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Dioseve with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Dioseve on 24 Mar 2026, and Hercules Pharmaceuticals on 13 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy